You searched for "Prostate" from the Body Image.

Stage	Phase	Principal Investigator	Study prefix	Study number	Title (click hyperlink for more information)
	II	Donald Trump, MD FACP	I	95406	Study of Serum 25(OH) D3 Level Variability in Response to Different Doses of Oral Vitamin D Supplementation in Prostate Cancer Patients
	III	Michael Kuettel, MD, PhD, MBA	NCG / RTOG	126608	(RTOG 0534) A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (Spport) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy
	IIB	James Mohler, MD	I	104607	A Randomized, Double-Blind, Placebo Controlled Clinical Trial of L-SeMet Supplementation and Finasteride Treatment of patients with prostate cancer prior to robotic prostatectomy /brachytherapy(Se and Finesteride Pre-Treatment Trial)
	I/II	Donald Trump, MD FACP	I	68905	A Phase I/II Study of Oral Calcitriol in Combination with Ketoconazole in Androgen Independent Prostate Cancer
	III	Ellis Levine, MD	NCG	89106	(ECOG E3805) CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial of Extensive Disease in Prostate Cancer
N/A	III	Ellis Levine, MD	NCG / CALGB	31504	(CALGB 90202): A Randomized Double-Blind, Placebo-Controlled Phase III Study of Early versus standard zoledronic acid to prevent skeletal related events in men with prostate cancer metastatic to bone
	III	James Mohler, MD	NCG / CALGB	115607	(CALGB 140602) A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer (START)
	III	James Mohler, MD	PH	143008	A Randomized, Open Label, Multicenter, Phase III, 2-Arm Study of Androgen Deprivation with Lepuprolode, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects with a Rising PSA Following Definitive Local Therapy
	III	Donald Trump, MD FACP	PH	139708	(CA 180227) A Randomized Double-Blind Phase 3 Trial Comparing Docetaxel Combined with Dasatinib to Docetaxel Combined with Placebo in Castration-Resistant Prostate Cancer
	III	James Mohler, MD	NCG / CALGB	100607	(CALGB 90203) A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
		Donald Trump, MD FACP	I	128308	Randomized Placebo-Controlled, Double-Blind Study Of Cholecalciferol Replacement in Patients on Expectant Management for Localized Prostate Cancer
	II	Donald Trump, MD FACP	PH	136408	A Phase 2, Multicenter, Randomized Study of IMC-A12 or IMC-1121B Plus Mitoxantrone and Prednisone in Metastatic Androgen-Independent Prostate Cancer (AIPC) Following Disease Progression on Docetaxel-Based Chemotherapy

Total number of Clinical Trials found: 12

Return to Search page